Minerals Technologies (MTX)
NYSEMaterialsChemicals - SpecialtySnapshot 2026-09-09
$69.22-1.84%
Close 2026-09-09 · 1-day change
NYSEMaterialsChemicals - SpecialtySnapshot 2026-09-09
Broken: Primary pillar broken — Sustain revenue growth above 5% annually: Q2 FY26 rev +4.0% vs 5.6% target.
Minerals Technologies grew sales 11% last year. Profit per share should reach $5.52 in 2026. The company is working to solve talc lawsuits. It pays a small dividend now.
Talc lawsuits could cost more than expected. Sales growth might slow below 5%. Profit per share could stay under $5.50.
The price is about 31% below our fair value near $108. Analysts expect about 6% revenue growth. We see risk in lawsuit costs and profit growth.
Breaks if: quarterly dividend falls below $0.12
Breaks if: EPS falls below $5.52 in FY26
Breaks if: YoY revenue growth falls below 5.6% next year
This is not a price target or investment advice.
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
This investment represents a turnaround story in the materials sector. The current thesis state reflects a cautious approach due to recent earnings misses and mixed operational results.
The market appears to have priced in a low expectations gap, indicating that investors are not overly optimistic about MTX's near-term performance. Valuation suggests that MTX is seen as cheap compared to its peers, but this is coupled with a justified assessment of its current financial challenges.
Management is focused on increasing revenue growth, which has shown some positive momentum. However, operating income has faced significant pressure due to special charges, leading to a mixed outlook on margin improvement.
The long-term thesis hinges on management's ability to execute on revenue growth and restore operating margins. Additionally, external factors such as inflation trends and performance of sector leaders will play a crucial role in shaping MTX's trajectory.
The most important moves since the prior daily snapshot.
Yes, our read has weakened. The latest earnings miss is a key reason. This miss shows the company is not meeting growth expectations. The overall market also shifted to a risk-off stance recently.
as of 2026-09-09
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Continue driving revenue growth through volume increases and market expansion across segments.
Stated as a priority in 3 of last 3 quarters. Consolidated sales grew from $491.8M in 2025-Q1 to $548.4M in 2026-Q2 (+11% and +4% respectively), with first half 2026 sales at $1.1B, up 7% year-over-year. Management consistently emphasized revenue growth momentum and remains on track for mid-single digit full-year growth, delivering against this priority.
“Sales momentum continued in Q2, resulting in 7% growth in first half of the year.”
“Sales grew by double digits across multiple businesses, momentum continuing in Q2.”
“Navigated market challenges while remaining focused on growth projects and strategic initiatives.”
Breaks if: talc-related charges exceed $290 million
Over the next 1 to 3 years, MTX's performance will depend on its operational execution and broader market conditions. Not investment advice.